SynthesisMedicine2026
Increased risk of stroke in patients with psoriasis: A systematic review and meta-analysis.
Synthesis in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsoriasis is a chronic inflammatory skin disorder affecting 2% to 3% of the global population and is increasingly linked to systemic complications, including cardiovascular events like stroke. This meta-analysis aimed to clarify the relationship between psoriasis and stroke risk.
methodsWe systematically searched PubMed, Google Scholar, and Cochrane databases for observational studies published through December 2024 that evaluated stroke risk in psoriasis patients. Studies were selected according to PRISMA guidelines, and data were extracted on patient characteristics, study design, and adjusted risk estimates.
resultsA total of 18 studies involving 705,602 psoriasis patients and 17,971,569 controls were included. Using a random-effects model, the overall pooled hazard ratio (HR) for stroke in psoriasis patients was 1.24 (95% confidence intervals [CI]: 1.15-1.35, P <.05). When stratified by disease severity, mild psoriasis had an HR of 1.09 (95% CI: 1.02-1.16), whereas severe psoriasis showed a higher risk with an HR of 1.36 (95% CI: 1.21-1.53). Regional analyses indicated increased stroke risk in Asia (HR = 1.08), Europe (HR = 1.26), and North America (HR = 1.49). Age subgroup analysis further supported a consistent association across different age groups.
conclusionOur meta-analysis indicates that psoriasis is associated with a significantly increased risk of stroke, particularly among patients with severe disease and older age. These findings highlights the importance of comprehensive cardiovascular risk management in individuals with psoriasis. Further research needed to explore the underlying mechanism in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.